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Abstract
Background: The conventional concept of radiation protection is based on epidemiological studies of radiation
that support a positive correlation between dose and response. However, there is a remarkable difference in
biological responses at the tissue level, depending on whether radiation is delivered as a uniform or non-uniform
spatiotemporal distribution due to tissue sparing effects (TSE). From the point of view of radiation micro-dosimetry,
environmental radiation is delivered as a non-uniform distribution, and radiation-induced biological responses at the
tissue level, such as TSE, would be implicated in individual risk following exposure to environmental radiation.
Hypothesis: We hypothesize that the health risks of non-uniform radiation exposure are lower than the same dose at
a uniform exposure, due to TSE following irradiation. Testing the hypothesis requires both radiobiological studies using
high-precision microbeams and the epidemiological data of environmental radiation-induced effects. The implications
of the hypothesis will lead to more personalized approaches in the field of environmental radiation protection.
Conclusion: The detection of spatiotemporal dose distribution could be of scientific importance for more accurate
individual risk assessment of exposure to environmental radiation. Further radiobiological studies on non-uniform
radiation-induced biological responses at the tissue level are expected.
Keywords: Environmental radiation, Radiation-induced biological effects, Tissue sparing effects, Health risk assessment,
Radiological protection
Background
Radiation-induced effects on biological tissues were
recognized immediately after the pivotal discovery of
X-rays by Wilhelm Röntgen in 1895 [1]. The first
radiation-related solid cancer was reported in 1902, aris-
ing in an ulcerated area of the skin, and, as reported in
1911, leukemia was diagnosed in five radiation workers
[2]. According to the results of previous epidemiological
studies, including the Life Span Study (LSS) of Japanese
atomic bomb survivors, these biological effects seem to
be dose-dependent with or without a threshold [3–6],
thus the current concept of radiological protection is
based on the dose-response model. In fact, for more
than four decades, according to reports and statements
of radiation research organizations, such as the US
National Council on Radiation Protection and Measure-
ments (NCRP) and the International Commission on
Radiological Protection (ICRP), a linear non-threshold
(LNT) model has been used for radiological protection
purposes [7, 8]. In May 2018, NCRP published the Com-
mentary No. 27, which supports the LNT model for
radiological protection, based on recent results of epi-
demiological studies of radiation [9], although there are
technical limitations to epidemiology, such as study de-
sign, sample size and confounding factors. Thus, the risk
assessment of environmental radiation exposure is still
based on the LNT model, although quantifying the risk
still remains problematic and subject to uncertainty [10].
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From the perspective of recent radiobiology, we high-
light a specific challenge: the contribution of spatiotem-
poral dose distribution might be underestimated in the
field of radiological protection. In an epidemiological co-
hort study of radiation, the researchers collected the data
of the total radiation dose each participant was exposed
to; however, it is technically difficult to have a clear
grasp of their accurate irradiation situations, such as ra-
diation dose rates or spatial distributions in the whole
body. This is one of the possible technical limitations of
the current epidemiological approach to radiation.
The quantity and quality of DNA damage is deter-
mined by the radiation type and dose [11]. For instance,
high and low linear-energy-transfer (LET) radiations in-
duce different spectra and qualities/complexity of DNA
lesions, due to the differences in radiation track struc-
tures [12]. This also impacts on the dose per cell deliv-
ered by individual tracks at low doses which will be
radiation quality dependent. Specifically, as shown in
Fig. 1, from the point of view of radiation micro-
dosimetry, for low-dose exposure, such as from environ-
mental radiation, or low-dose rates of radiation, the en-
ergy deposition of radiation is localized along its track,
resulting in a non-uniform distribution of exposed or
unexposed cells in irradiated tissue [13, 14]. Thus, for
environmental radiation, there are possible interactions
between the irradiated and the non-irradiated cells and
the dynamics of these cells in the tissue involved in
radiation-induced biological responses at the whole-
tissue level [15]. In fact, it is well known that cells that
do not receive radiation doses directly but receive signals
from nearby or neighboring irradiated cells behave as
though they have been exposed [16, 17]. These well-
documented responses are collectively known as non-
targeted effects, although the underlying molecular
mechanisms are not completely understood [18]. How-
ever, the conventional concept of radiological protection
has not taken into consideration such tissue-level re-
sponses following exposure to environmental radiation.
In clinical practice, the tissue-sparing response in
non-uniform radiation fields was recognized more than
one century ago. In 1909, Alban Köhler reported the
first clinical observation of a tissue-sparing response
during grid radiotherapy in which spatially fractionated
radiation was delivered using a grid-like pattern of
beams [19]. In 1995, a notable tissue-sparing was re-
ported in rat brain tissues during a microbeam radiation
therapy (MRT) study [20], performed at the National
Synchrotron Light Source, Brookhaven National Labora-
tory. Since then, the tissue-sparing effect (TSE) of MRT,
which is based on a spatial fractionation of synchrotron-
generated X-ray microbeams at the microscale level, has
been confirmed in a large variety of species and tissue
types, although the underlying mechanism of TSE re-
mains to be established [19–25]. The TSE of spatial-
fractionated radiation indicates significant implications
not only for clinical applications, but also for the im-
provement of risk assessment of exposure to non-
uniform radiation, such as environmental radiation.
For a more accurate risk assessment of exposure to
Fig. 1 Low-dose radiation dose distributions at micro-scale level. This is a simulated result of exposure to dose levels of approximately 1 mGy/year.
The distribution of the dose is tempo-spatially heterogenous. The blue lines indicate radiation tracks in the irradiated tissue
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environmental radiation, the assessment of the spatio-
temporal dose distribution could be of scientific im-
portance due to the TSE.
Presentation of the hypothesis
As shown in Fig. 2, intercellular responses, such as
apoptosis and clearance of apoptotic cells, cell competi-
tion and tissue repair/regeneration, would be involved in
TSE in response to non-uniform radiation fields.
Depending on the efficiency of acute cellular responses
following irradiation, the damaged cells either survive or
are removed from the tissue. In general, if radiation-
induced damages of cellular components, in particular
DNA, are not repaired sufficiently, the damaged cells
will commit suicide in a process called apoptosis, which
is a clearance system in multicellular organisms [26, 27].
Further, for tissue homeostasis, cell competition is essen-
tial as a cell fitness-sensing mechanism seen from in-
sects to mammals that eliminates cells that, although
viable, are less fit than their neighbors [28]. Damaged
cells induced by non-uniform radiation would be re-
moved by the neighboring cells due to cell competition,
resulting in the prevention of a pathological state, such
as carcinogenesis [29]. In addition, to remove cancer
cells, interactions between the immune system and can-
cer governed by a complex network of biological
pathways are a rapidly developing research area [30].
The therapeutic effects of radiotherapy have been ob-
served not only in cancer cells, but also in their micro-
environment. Today the role of the host’s immune
system in the mechanisms of tumor regression by gener-
ating a cytotoxic adaptive immune response is well de-
scribed and is recognized as immunogenic cell death
(ICD) [31]. In this complex myriad of events, intrinsic
characteristics of the tumor cells (tumor type, immuno-
genic capacity) and the immune status of the host are
important factors determining the successful induction
of ICD [32]. In addition to the potential synergism in
terms of local control, the possibility to obtain systemic
responses, described initially by Mole in 1953 as “the
abscopal effect [33],” mediated by ICD has stimulated
great interest. After the complete clearance of damaged
cells, tissue repair/regeneration generally occurs for the
maintenance of normal tissue functions, namely homeo-
stasis. Somatic stem cells migrate from the intact to the
defective parts and regenerate the structure and function
of tissue by their proliferation and differentiation
[34, 35]. Such tissue homeostasis mechanisms could
be involved in radiation-induced biological responses
at the tissue level. However little is know, particu-
larly with respect to immune system modulation at
low environmental doses.
Fig. 2 Radiation-induced biological responses at the tissue level. When cell-level repair responses (e.g. DNA damage repair, and oxidative stress
response) cannot completely repair the radiation-induced damages, the removal of damaged cells (e.g. apoptosis, and cell competition) and tissue
structure repair/regeneration (e.g. stem cell migration and proliferation) minimize the influence for maintaining normal tissue functions. The removals of
damaged cells prevent the tissue from carcinogenesis or senescence that are targets of immune system. The failures of tissue structure repair/regeneration
induce wholly or partially the dysfunction
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We do not intend to question the conventional LNT
concept for radiological protection purposes. Our aim is
to suggest further studies on the mechanisms of
radiation-induced biological responses at the tissue level
for a more accurate estimation of environmental
radiation risk. We hypothesize that the health risks of
environmental radiation exposure are prone to be over-
estimated because at the very least radiation-induced
biological responses at the tissue level, especially TSE,
are not adequately considered. Conventionally, animal
studies have been commonly used to investigate the
radiation-induced biological responses at the tissue level.
However, most of these studies have been performed by
uniform radiation exposure, such as total body irradi-
ation, thus the knowledge on tissue homeostasis re-
sponses following exposure to non-uniform radiation,
such as environmental radiation, appears to be insuffi-
cient even now.
Testing the hypothesis
Because the technology of MRT has only recently been
developed, the molecular mechanisms of TSE in re-
sponse to non-uniform radiation fields have not yet been
fully determined. As we suggest in this paper, there
appears to be several potential biological responses in-
volved in tissue homeostasis after exposure to non-uni-
form radiation, such as environmental radiation. Given
the use of high-precision microbeams, further radiobio-
logical studies on such biological responses are foreseen.
Key to this will be an appropriate assessment of the
interrelationship between dose and its localization in tis-
sue volumes.
Also, epidemiological studies of non-uniform radiation-
induced biological effects will provide a more comprehen-
sive radiological understanding of response mechanisms,
leading to improved accuracy in the estimations of envir-
onmental radiation risk. The confirmation of spatiotem-
poral dose distribution of environmental radiation will be
of scientific importance in such studies.
Implications of the hypothesis
The hypothesis will suggest reconsidering the concept of
the health-risk assessment of environmental radiation
from the viewpoint of precision medicine. If the evi-
dence for the hypothesis can be strengthened by appro-
priate radiobiological and epidemiological studies, the
target of current environmental radiation risk assess-
ment approaches will show a dramatic change from the
“average person” to “each person”. To consider individ-
ual spatiotemporal exposure to radiation will provide a
novel insight into individual risk assessment of environ-
mental radiation. For the coming era of precision medi-
cine, in addition to the consideration of genomic factors
[36], the global scientific community, including such
bodies as NCRP and ICRP, need to consider how to inte-
grate similar personalized approaches into a future con-
cepts of radiological protection. We hope that our
hypothesis will stimulate scientific debate in the field.
Since the large-scale nuclear disasters in Chernobyl, in
1986, and in Fukushima, in 2011, there has been a great
deal of public concern about the possible health effects
of long-term and low-dose radiation exposure on
current and future generations [37–39]. Previous data
based on population cohorts, such as the LSS, estimate
that the risk of cancer from radiation exposure will in-
crease at doses exceeding approximately 100 mSv [4, 5],
although there are technical limitations and biases [40].
These data, however, are mainly based on acute irradi-
ation situations, such as the explosion of the atomic
bomb, and could not take weighting factors of spatio-
temporal dose distributions into consideration. The
hypothesis we suggest would provide a novel ap-
proach for more accurate individual risk assessment
of such low-dose and long-term environmental radi-
ation exposures.
Risk assessment of exposure to environmental radi-
ation is essential for human activity in space. As future
missions explore beyond low-Earth orbit (LEO) and
away from the protection of the Earth’s magnetic shield-
ing, the nature of radiation exposure that astronauts en-
counter will include higher radiation exposures [41].
During transit outside of LEO, every cell nucleus within
an astronaut’s body would be traversed by a proton or
electron ray every few days, and by a heavier galactic
cosmic ray ion (e.g., O, Si, Fe) every few months [42].
For a more accurate risk assessment of exposure to such
an environment, the understanding of non-uniform,
radiation-induced biological responses at the tissue level
will be of scientific importance.
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